184 related articles for article (PubMed ID: 12203787)
21. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
[TBL] [Abstract][Full Text] [Related]
22. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
23. Novel tumorigenic rearrangement, Delta rfp/ret, in a papillary thyroid carcinoma from externally irradiated patient.
Saenko V; Rogounovitch T; Shimizu-Yoshida Y; Abrosimov A; Lushnikov E; Roumiantsev P; Matsumoto N; Nakashima M; Meirmanov S; Ohtsuru A; Namba H; Tsyb A; Yamashita S
Mutat Res; 2003 Jun; 527(1-2):81-90. PubMed ID: 12787916
[TBL] [Abstract][Full Text] [Related]
24. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.
Fusco A; Chiappetta G; Hui P; Garcia-Rostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G
Am J Pathol; 2002 Jun; 160(6):2157-67. PubMed ID: 12057919
[TBL] [Abstract][Full Text] [Related]
25. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
[TBL] [Abstract][Full Text] [Related]
26. RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material.
Williams GH; Rooney S; Thomas GA; Cummins G; Williams ED
Br J Cancer; 1996 Aug; 74(4):585-9. PubMed ID: 8761374
[TBL] [Abstract][Full Text] [Related]
27. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N
J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189
[TBL] [Abstract][Full Text] [Related]
28. HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma.
Ciampi R; Giordano TJ; Wikenheiser-Brokamp K; Koenig RJ; Nikiforov YE
Endocr Relat Cancer; 2007 Jun; 14(2):445-52. PubMed ID: 17639057
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia.
Chua EL; Wu WM; Tran KT; McCarthy SW; Lauer CS; Dubourdieu D; Packham N; O'Brien CJ; Turtle JR; Dong Q
J Clin Endocrinol Metab; 2000 Aug; 85(8):2733-9. PubMed ID: 10946873
[TBL] [Abstract][Full Text] [Related]
30. 3' Splicing variants of ret receptor tyrosine kinase are differentially expressed in mouse embryos and in adult mice.
Lee KY; Samy ET; Sham MH; Tam PK; Lui VC
Biochim Biophys Acta; 2003 May; 1627(1):26-38. PubMed ID: 12759189
[TBL] [Abstract][Full Text] [Related]
31. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas.
Lee CH; Hsu LS; Chi CW; Chen GD; Yang AH; Chen JY
J Clin Endocrinol Metab; 1998 May; 83(5):1629-32. PubMed ID: 9589668
[TBL] [Abstract][Full Text] [Related]
32. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
[TBL] [Abstract][Full Text] [Related]
33. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas.
Learoyd DL; Messina M; Zedenius J; Guinea AI; Delbridge LW; Robinson BG
J Clin Endocrinol Metab; 1998 Oct; 83(10):3631-5. PubMed ID: 9768676
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.
Bongarzone I; Monzini N; Borrello MG; Carcano C; Ferraresi G; Arighi E; Mondellini P; Della Porta G; Pierotti MA
Mol Cell Biol; 1993 Jan; 13(1):358-66. PubMed ID: 7678053
[TBL] [Abstract][Full Text] [Related]
35. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas.
Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M
Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340
[TBL] [Abstract][Full Text] [Related]
36. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.
Klugbauer S; Pfeiffer P; Gassenhuber H; Beimfohr C; Rabes HM
Genomics; 2001 Apr; 73(2):149-60. PubMed ID: 11318605
[TBL] [Abstract][Full Text] [Related]
37. Development of a single-step duplex RT-PCR detecting different forms of ret activation, and identification of the third form of in vivo ret activation in human papillary thyroid carcinoma.
Jhiang SM; Smanik PA; Mazzaferri EL
Cancer Lett; 1994 Apr; 78(1-3):69-76. PubMed ID: 8180971
[TBL] [Abstract][Full Text] [Related]
38. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.
Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A
Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903
[TBL] [Abstract][Full Text] [Related]
39. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
Grieco M; Santoro M; Berlingieri MT; Melillo RM; Donghi R; Bongarzone I; Pierotti MA; Della Porta G; Fusco A; Vecchio G
Cell; 1990 Feb; 60(4):557-63. PubMed ID: 2406025
[TBL] [Abstract][Full Text] [Related]
40. Differential interaction of Enigma protein with the two RET isoforms.
Borrello MG; Mercalli E; Perego C; Degl'Innocenti D; Ghizzoni S; Arighi E; Eroini B; Rizzetti MG; Pierotti MA
Biochem Biophys Res Commun; 2002 Aug; 296(3):515-22. PubMed ID: 12176011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
